• Publications
  • Influence
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology
TLDR
The incidence of pelvic nodal metastasis in a large cohort of endometrial cancer patients of uniform histologic subtype in relation to tumor grade and a one-half myometrial invasion cutoff is determined. Expand
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
TLDR
Following the change in surgical paradigm that the incorporated extensive upper abdominal procedures to attain optimal debulking, preoperative CA-125 did not predict the primary cytoreductive outcome of patients with advanced ovarian, tubal, or peritoneal carcinoma. Expand
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
TLDR
Utilizing six readily accessible predictor variables, a nomogram more accurately predicted 5-year disease-specific survival for bulky stage IIIC EOC than the previously published model and may be useful for patient counseling, determination of clinical trial eligibility, and postoperative management. Expand
The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer
Epidermal growth factor receptor (EGFR) inhibitors are a new biologically targeted therapy, which may offer new hope in the treatment of patients with advanced or recurrent ovarian cancers. In thisExpand
Recurrent Hemorrhagic Ascites: A Rare Presentation of Endometriosis
TLDR
Endometriosis should be considered in the differential diagnosis of recurrent hemorrhagic ascites in premenopausal women, because the diagnosis always requires operative assessment and histologic confirmation. Expand